LARP4B and liver cancer: Subgroup analysis showed that LARP4B expression had a prognostic value in liver cancer patients who were T4 (P = 0.049), male (P = 0.014), stage III/IV (P = 0.037), G1/G2 (P = 0.022), and older (P = 0.024).